Trial Profile
Phase IB Study of Biomarker Modulation by Celecoxib vs. Placebo in Women With Newly-Diagnosed Breast Cancer.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Celecoxib (Primary)
- Indications Breast cancer
- Focus Biomarker; Therapeutic Use
- 15 Oct 2008 New trial record.